Amer Bio Medica Stock Current Liabilities
| ABMCDelisted Stock | USD 0.01 0 38.00% |
Amer Bio Medica fundamentals help investors to digest information that contributes to Amer Bio's financial success or failures. It also enables traders to predict the movement of Amer Pink Sheet. The fundamental analysis module provides a way to measure Amer Bio's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Amer Bio pink sheet.
Amer |
Amer Bio Medica Company Current Liabilities Analysis
Amer Bio's Current Liabilities is the company's short term debt. This usually includes obligations that are due within the next 12 months or within one fiscal year. Current liabilities are very important in analyzing a company's financial health as it requires the company to convert some of its current assets into cash.
Current Amer Bio Current Liabilities | 1.62 M |
Most of Amer Bio's fundamental indicators, such as Current Liabilities, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Amer Bio Medica is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Current liabilities appear on the company's balance sheet and include all short term debt accounts, accounts and notes payable, accrued liabilities as well as current payments due on the long-term loans. One of the most useful applications of Current Liabilities is the current ratio which is defined as current assets divided by its current liabilities. High current ratios mean that current assets are more than sufficient to pay off current liabilities.
CompetitionIn accordance with the recently published financial statements, Amer Bio Medica has a Current Liabilities of 1.62 M. This is 99.91% lower than that of the Health Care Equipment & Supplies sector and 99.69% lower than that of the Health Care industry. The current liabilities for all United States stocks is 99.98% higher than that of the company.
Amer Current Liabilities Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Amer Bio's direct or indirect competition against its Current Liabilities to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Amer Bio could also be used in its relative valuation, which is a method of valuing Amer Bio by comparing valuation metrics of similar companies.Amer Bio is currently under evaluation in current liabilities category among its peers.
Amer Fundamentals
| Return On Asset | -0.42 | ||||
| Profit Margin | (1.13) % | ||||
| Operating Margin | (0.93) % | ||||
| Current Valuation | 2.09 M | ||||
| Shares Outstanding | 48.1 M | ||||
| Shares Owned By Insiders | 31.26 % | ||||
| Number Of Shares Shorted | 5.13 K | ||||
| Price To Earning | (6.72) X | ||||
| Price To Sales | 0.38 X | ||||
| Revenue | 2.22 M | ||||
| Gross Profit | 548 K | ||||
| EBITDA | (199 K) | ||||
| Net Income | (463 K) | ||||
| Cash And Equivalents | 2 K | ||||
| Total Debt | 1.53 M | ||||
| Debt To Equity | 0.85 % | ||||
| Current Ratio | 0.25 X | ||||
| Book Value Per Share | (0.04) X | ||||
| Cash Flow From Operations | (673 K) | ||||
| Short Ratio | 0.09 X | ||||
| Earnings Per Share | (0.01) X | ||||
| Number Of Employees | 32 | ||||
| Beta | -0.69 | ||||
| Market Capitalization | 480.99 K | ||||
| Total Asset | 1.88 M | ||||
| Retained Earnings | (21.24 M) | ||||
| Working Capital | 937 K | ||||
| Current Asset | 2.56 M | ||||
| Current Liabilities | 1.62 M | ||||
| Z Score | -14.4 | ||||
| Net Asset | 1.88 M |
About Amer Bio Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Amer Bio Medica's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Amer Bio using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Amer Bio Medica based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.
Other Consideration for investing in Amer Pink Sheet
If you are still planning to invest in Amer Bio Medica check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Amer Bio's history and understand the potential risks before investing.
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Bonds Directory Find actively traded corporate debentures issued by US companies |